Acadia Healthcare (NASDAQ:ACHC) Rating Increased to Overweight at KeyCorp

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was upgraded by stock analysts at KeyCorp from a "sector weight" rating to an "overweight" rating in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage currently has a $70.00 price objective on the stock. KeyCorp's target price suggests a potential upside of 55.11% from the stock's current price.

Several other analysts have also commented on ACHC. StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday. Cantor Fitzgerald restated a "neutral" rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada lowered their price target on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a research report on Monday, November 18th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a "hold" rating to a "buy" rating and upped their target price for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, Barclays decreased their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $70.22.

Acadia Healthcare Stock Performance

Shares of ACHC stock traded up $0.28 during trading hours on Tuesday, hitting $45.13. The company's stock had a trading volume of 2,328,060 shares, compared to its average volume of 2,337,040. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a 50 day moving average of $40.57 and a 200 day moving average of $58.37. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The stock has a market cap of $4.19 billion, a PE ratio of 14.80, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $0.91 EPS. On average, sell-side analysts forecast that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC grew its stake in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare in the 2nd quarter valued at $59,000. Covestor Ltd raised its position in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock worth $72,000 after buying an additional 1,018 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in shares of Acadia Healthcare in the 3rd quarter worth $86,000. Finally, Assetmark Inc. boosted its holdings in shares of Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company's stock valued at $94,000 after acquiring an additional 591 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.